Published in Am J Physiol on June 01, 1999
Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun (1998) 7.86
Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol (2013) 4.34
Intestinal bacteria and the regulation of immune cell homeostasis. Annu Rev Immunol (2010) 2.85
Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J Exp Med (2002) 2.60
Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation. Infect Immun (2001) 1.99
Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis. Gut (2005) 1.95
Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun (2001) 1.94
Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol (2002) 1.79
Role of Toll-like receptors in gastrointestinal malignancies. Oncogene (2008) 1.69
Bacteria, inflammation, and colon cancer. World J Gastroenterol (2006) 1.67
The intestinal microbiota in health and disease: the influence of microbial products on immune cell homeostasis. Curr Opin Gastroenterol (2009) 1.57
Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice. Am J Pathol (2002) 1.50
Contrasting activity of cytosin-guanosin dinucleotide oligonucleotides in mice with experimental colitis. Clin Exp Immunol (2003) 1.45
Layers of mutualism with commensal bacteria protect us from intestinal inflammation. Gut (2006) 1.36
Bacterial probiotic modulation of dendritic cells. Infect Immun (2004) 1.35
Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-deficient mice. Infect Immun (2000) 1.33
Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis. Clin Diagn Lab Immunol (2004) 1.32
The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes (2012) 1.32
Experimental Models of Inflammatory Bowel Diseases. Cell Mol Gastroenterol Hepatol (2015) 1.20
Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cells. Eur J Immunol (2009) 1.18
Host-microbial interactions and regulation of intestinal epithelial barrier function: From physiology to pathology. World J Gastrointest Pathophysiol (2012) 1.09
Gut microbiota protects against gastrointestinal tumorigenesis caused by epithelial injury. Cancer Res (2013) 1.00
A guide to histomorphological evaluation of intestinal inflammation in mouse models. Int J Clin Exp Pathol (2014) 0.99
Intestinal heat shock protein 110 regulates expression of CD1d on intestinal epithelial cells. J Clin Invest (2003) 0.96
The gastrointestinal microbiota and colorectal cancer. Am J Physiol Gastrointest Liver Physiol (2014) 0.94
IL-2: a two-faced master regulator of autoimmunity. J Autoimmun (2011) 0.93
Impact of the gut microbiota on rodent models of human disease. World J Gastroenterol (2014) 0.92
T-cell selection and intestinal homeostasis. Immunol Rev (2014) 0.92
Community dynamics in the mouse gut microbiota: a possible role for IRF9-regulated genes in community homeostasis. PLoS One (2010) 0.92
Guanylate cyclase C deficiency causes severe inflammation in a murine model of spontaneous colitis. PLoS One (2013) 0.91
Loss of CD103+ intestinal dendritic cells during colonic inflammation. World J Gastroenterol (2010) 0.90
Bifidobacterium animalis causes extensive duodenitis and mild colonic inflammation in monoassociated interleukin-10-deficient mice. Inflamm Bowel Dis (2009) 0.90
T cell-mediated oral tolerance is intact in germ-free mice. Clin Exp Immunol (2006) 0.90
Bifidobacterium lactis attenuates onset of inflammation in a murine model of colitis. World J Gastroenterol (2011) 0.88
Chronic colitis induces expression of β-defensins in murine intestinal epithelial cells. Clin Exp Immunol (2010) 0.88
Disrupted B-lymphocyte development and survival in interleukin-2-deficient mice. Immunology (2001) 0.87
Reduced susceptibility to dextran sulphate sodium-induced colitis in the interleukin-2 heterozygous (IL-2) mouse. Immunology (2005) 0.86
Genetic and Chemical Models of Colorectal Cancer in Mice. Curr Colorectal Cancer Rep (2010) 0.85
Microbial sensing by the intestinal epithelium in the pathogenesis of inflammatory bowel disease. Int J Inflam (2010) 0.85
Regulatory T Cells Control Immune Responses through Their Non-Redundant Tissue Specific Features. Front Immunol (2013) 0.84
Guanylate cyclase C limits systemic dissemination of a murine enteric pathogen. BMC Gastroenterol (2013) 0.83
Paneth cell α-defensins and enteric microbiota in health and disease. Biosci Microbiota Food Health (2015) 0.82
Serum interleukin-1 receptor antagonist is an early indicator of colitis onset in Galphai2-deficient mice. World J Gastroenterol (2006) 0.82
Macrophages in the small intestinal muscularis externa of embryos, newborn and adult germ-free mice. J Mol Histol (2004) 0.82
Intestinal colonization of IL-2 deficient mice with non-colitogenic B. vulgatus prevents DC maturation and T-cell polarization. PLoS One (2008) 0.80
Host and microbiota interactions are critical for development of murine Crohn's-like ileitis. Mucosal Immunol (2015) 0.80
Distinct elevation of levels of anti-Caenorhabditis elegans antibody in sera of patients with inflammatory bowel disease. Clin Diagn Lab Immunol (2003) 0.79
Mouse models of colorectal cancer. Chin J Cancer (2011) 0.78
Cytotoxicity of organic acids produced by anaerobic intestinal bacteria on cultured epithelial cells. J Gastroenterol (2005) 0.78
Recent advances in basic and clinical aspects of inflammatory bowel disease: which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease? World J Gastroenterol (2007) 0.77
Luminal bacterial antigen-specific CD4+ T-cell responses in HLA-B27 transgenic rats with chronic colitis are mediated by both major histocompatibility class II and HLA-B27 molecules. Immunology (2006) 0.77
Maintaining intestinal health: the genetics and immunology of very early onset inflammatory bowel disease. Cell Mol Gastroenterol Hepatol (2015) 0.77
T cells and intestinal commensal bacteria--ignorance, rejection, and acceptance. FEBS Lett (2014) 0.76
Interaction of gut microbiota with bile acid metabolism and its influence on disease states. Appl Microbiol Biotechnol (2016) 0.75
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell (1993) 11.95
Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun (1998) 7.86
Experimental models of inflammatory bowel disease. Gastroenterology (1995) 6.28
Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature (1991) 5.51
The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med (1994) 5.46
Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell (1996) 4.74
Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest (1996) 4.59
Propagation of both parental mitochondrial DNAs in rat-human and mouse-human hybrid cells. J Mol Biol (1973) 3.93
Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J Immunol (1995) 3.69
Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE (2000) 3.45
Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur J Immunol (1995) 3.34
Candidate gene associated with a mutation causing recessive polycystic kidney disease in mice. Science (1994) 3.31
Immune responses in interleukin-2-deficient mice. Science (1993) 3.29
Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology (1992) 3.04
CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev (1998) 2.91
Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J Biol Chem (1999) 2.79
Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol Cell (2000) 2.70
Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol (1999) 2.55
Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry (1999) 2.50
Susceptibility locus for Alzheimer's disease on chromosome 10. Science (2000) 2.49
Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer. J Clin Oncol (1999) 2.38
Interleukin 2, but not other common gamma chain-binding cytokines, can reverse the defect in generation of CD4 effector T cells from naive T cells of aged mice. J Exp Med (1999) 2.33
Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J Clin Invest (2000) 2.27
The I kappa B/NF-kappa B system: a key determinant of mucosalinflammation and protection. Am J Physiol Cell Physiol (2000) 2.21
Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor. Hepatology (1998) 2.18
Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol Cell Biol (2000) 2.15
Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation (1993) 2.03
Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut (2003) 2.02
Tsetse immune responses and trypanosome transmission: implications for the development of tsetse-based strategies to reduce trypanosomiasis. Proc Natl Acad Sci U S A (2001) 2.02
Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect Immun (1990) 2.00
Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun (2001) 1.94
Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains. Infect Immun (1998) 1.87
The role of thymus-dependent cell-mediated immunity in resistance to experimental disseminated candidiasis. J Reticuloendothel Soc (1976) 1.87
Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect Immun (1999) 1.85
CD4+CD8- T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J Immunol (1994) 1.83
Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Proc Natl Acad Sci U S A (2000) 1.82
Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells. J Immunol (1997) 1.80
Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias. Blood (1998) 1.80
Gamma delta T cell-induced nitric oxide production enhances resistance to mucosal candidiasis. Nat Med (1995) 1.80
Acquired immunity to systemic candidiasis in immunodeficient mice. J Infect Dis (1991) 1.80
Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone. Gastroenterology (2001) 1.77
Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis. J Exp Med (1997) 1.77
The bacterial etiology of pneumatosis cystoides intestinalis. Arch Surg (1974) 1.75
Macrophages in resistance to candidiasis. Microbiol Mol Biol Rev (1997) 1.74
Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline. Gastroenterology (1991) 1.72
Growth and invasiveness of Candida albicans in the germ-free and conventional mouse after oral challenge. Appl Microbiol (1966) 1.69
Effect of oral tetracycline, the microbial flora, and the athymic state on gastrointestinal colonization and infection of BALB/c mice with Candida albicans. Infect Immun (1979) 1.67
Immunity to Candida albicans. Microbiol Rev (1980) 1.66
Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth. Gastroenterology (1990) 1.59
Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments. Gastroenterology (1985) 1.57
Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4. Eur J Immunol (1994) 1.57
Role of CD4+ lymphocytes in resistance to mucosal candidiasis. Infect Immun (1991) 1.55
Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats. Gastroenterology (1993) 1.54
Family of middle repetitive DNA sequences in the mouse genome with structural features of solitary retroviral long terminal repeats. Proc Natl Acad Sci U S A (1983) 1.54
Control of dimorphism in a biochemical variant of Candida albicans. J Bacteriol (1969) 1.53
Growth, morphogenesis, and virulence of Candida albicans after oral inoculation in the germ-free and conventional chick. J Bacteriol (1966) 1.53
Pseudomembranous colitis in Clostridium difficile-monoassociated rats. Infect Immun (1983) 1.51
Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor kappaB super-repressor in human intestinal epithelial cells. J Immunol (1998) 1.51
Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice. Proc Natl Acad Sci U S A (1999) 1.50
Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein. Blood (1999) 1.49
Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases. J Intern Med (2008) 1.48
Increased sitosterol absorption, decreased removal, and expanded body pools compensate for reduced cholesterol synthesis in sitosterolemia with xanthomatosis. J Lipid Res (1989) 1.47
Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats. Gastroenterology (1999) 1.47
Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus genes. Science (1991) 1.46
Morphology, Physiology, and Virulence of Some Mutants of Candida albicans. Infect Immun (1971) 1.45
Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats. Gastroenterology (1994) 1.45
The role of IL4 and IL5: characterization of a distinct helper T cell subset that makes IL4 and IL5 (Th2) and requires priming before induction of lymphokine secretion. Immunol Rev (1988) 1.44
Targeted inactivation of the tetraspanin CD37 impairs T-cell-dependent B-cell response under suboptimal costimulatory conditions. Mol Cell Biol (2000) 1.44
Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tg(epsilon26) mice. Gastroenterology (2001) 1.43
Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolemia with xanthomatosis. J Lipid Res (1985) 1.43
An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42
Intestinal inflammation reduces expression of DRA, a transporter responsible for congenital chloride diarrhea. Am J Physiol (1998) 1.41
The synthesis of poxvirus-specific RNA in interferon-treated cells. Virology (1972) 1.38
A monoclonal antibody to gamma interferon blocks augmentation of natural killer cell activity induced during systemic cryptococcosis. Infect Immun (1991) 1.35
Peroxynitrite contributes to the candidacidal activity of nitric oxide-producing macrophages. Infect Immun (1996) 1.35
Germ-tube production by Candida albicans in minimal liquid culture media. Can J Microbiol (1971) 1.34
Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-deficient mice. Infect Immun (2000) 1.33
The known distribution and ecological preferences of the tick subgenus Boophilus (Acari: Ixodidae) in Africa and Latin America. Exp Appl Acarol (2006) 1.33
Structure and genomic organization of a new family of murine retrovirus-related DNA sequences (MuRRS). Nucleic Acids Res (1985) 1.33
Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers. Gut (1996) 1.31
Resistance of SCID mice to Candida albicans administered intravenously or colonizing the gut: role of polymorphonuclear leukocytes and macrophages. J Infect Dis (1993) 1.30
The role of environmental antigens in the spontaneous development of autoimmunity in MRL-lpr mice. J Immunol (1999) 1.30
Cytokines induce NF-kappaB in activated but not in quiescent rat hepatic stellate cells. Am J Physiol (1998) 1.29
A recombination hotspot in the LTR of a mouse retrotransposon identified in an in vitro system. Cell (1989) 1.29
Colonization and infection of athymic and euthymic germfree mice by Campylobacter jejuni and Campylobacter fetus subsp. fetus. Infect Immun (1986) 1.28
The mouse poly(C)-binding protein exists in multiple isoforms and interacts with several RNA-binding proteins. Nucleic Acids Res (1996) 1.28
Expression of the neutrophil chemokine KC in the colon of mice with enterocolitis and by intestinal epithelial cell lines: effects of flora and proinflammatory cytokines. J Immunol (1999) 1.28
Unaltered phenotype, tissue distribution and function of Valpha14(+) NKT cells in germ-free mice. Eur J Immunol (2000) 1.27